REFERENCIAS BIBLIOGRAFICAS

1. Grisolia JS, Wiederholt WC. CNS cysticercosis. Arch Neurol 1982; 39: 540-4.
2. Garcia HH, Martinez M. Gilman RH, Herrera G, et al. The Cysticercosis Working Group in Peru. Diagnosis of cysticercosis in endemic regions. Lancet 1991; 338: 549-51. 
3. Brown WJ, Voge M. Cysticercosis: A modern day plague. Pediatr Clin North Am 1985; 32. 953-69.
4. Bousquet CF. Dufour TF, Derome PC. Retrobulbar optic nerve cysticercosis. J Neurosurg 84: 293-6.
5. Levav M, Mirsky AF, Cruz ME, Cruz I. Neurocysticercosis and performance on neuropsychologic tests: A family study in Ecuador. Am J Trop Med Hyg 1995; 53: 552-7. 
6. Richards FO, Schantz PM, Ruiz-Tiben E, Sorvillo FJ. Cysticercosis in LosAngeles County. JAMA 1985; 254 (24): 3444-8.
7. Botero D, Restrepo M. Parasitosis tisulares par larval de helmintos: Cisticercosis. En: Parasitosis Humaras. Corporación para Investigaciones Biológicas. Medellin-Colombia 1992, 315-27.
8. Reyes H. Cisticercosis. En: Parasitología Clinica. Atías-Neghme, Publicaciones Técnicas Mediterráneo, Santiago - Chile 1991.355-9.
9. The Cystkercosis Working Group in Peru. The marketing of cysticercotic pigs in the Sierra of Peru. Bulletin of the World Health Organization 1993; 71(2): 223-8.
10. Gonzales AE, Cama V, Gilman RH, Tsang V, Pilcher JB, Chavera A, et al. Prevalence and comparison of serologic assays, necropsy, and tongue examination for the diagnosis of porcine cysticercosis in Peru. Am J Trop Med Hyg 1990; 43(2): 194-9.
11. Sarti E, Schantz PM, Plancarte A, Wilson M, Gutierrez FO, López AS, Roberts J. Flisser A. Prevalence and risk factors for Taeniasis solum taeniasis and cysticercosis in humans and pigs in a village in Morelos, Mexico Am J Trop Med Hyg 1992;46(2):677-85.
12. Flisser A, Madrazo I, Gonzáles D, Sandoval M, Rodríguez-Carbajal J, De Dios J. Comparative analysis of human and porcine neurocysticercosis by computed tomography. Trans R Soc Trop Med Hyg 1988; 82: 739-42.
13. Escajadillo V: Prevalencia de anticuerpos a teniasis-cisticercosis en expendedores de chicharrones en Saylla-Cusco (tesis de Bachiller) Lima, Peru: Universidad Peruana Cayetano Heredia, 1994.
14. Diaz F, Garcia HH, Gilman RH, Gonzáles AE, Castro M, et al, The Cysticercosis Working Group in Peru. Epidemiology of Taeniasis and Cysticercosis in a Peruvian Village. Am J Epidemiol 1992; 135: 875-82.
15. Del Brutto OH, Sotelo J. Neurocysticercosis: An update Rev infect Dis 1988; 
10:1075-87.
16. Diaz S, Candil A, Uribe M, Willms K. Serology as an indicator of Taenia solium tapeworm infections in a rural community in Mexica. Trans R Soc Trop Med Hyg 1990; 84: 563-6
17. Bending J, Carford J. Epidemic of burns in New Guinea due to cerebral cysticercosis. Lancet 1983; is 922.
18. Medina M, Rosas E, Rubio-Donnadeu F, Sotelo J. Neurocysticercosis as the main cause of late-onset epilepsy in Mexico Arch Intern Med 1990; 150: 325-7.
19. Cruz I, Cruz ME, Teran W, Schantz M, Tsang V, Barry M. Human subcutaneous Taenia solium cysticercosis in an andean population with neurocysticercosis. Am J Trop Med Hyg 1994; 51(4): 405-7.
20. Andriantsimahavandy A, Lesbordes JL, Rasoaharimlala B, Peghini M, Rabarijaona L, Roux J, Boisier P. Neurocysticercosis: a major aetiological factor of late-onset epilepsy in Madagascar Trop Med Int Health 1997; 2(8) 741-6.
21. Garcia HH, Gilman RH, Tsang V, Gonzales AE. The Cysticercosis Working Group in Peru. Clinical significance of neurocysticercosis in endemic villages. Trans R Soc Trop Med Hyg 1997; 91(2): 176-8.
22. Agapejev S. Epidemiology of neurocysticercosis in Brazil. Rev Inst Med Trop Sao Paulo 1996; 38(3): 207-16.
23. Garcia HH. TAC en cisticercosis cerebral: Correlato imagenológico, clínico y de laboratorio Estudio retrospective de 354 casos (Tesis de Bachiller) Lima, Perú: Universidad Peruana Cayetano Heredia, 1989.
24. Buitrago M, Edwards B, Rosner F Neurocystkercosis: report of fifteen cases. Mt Sinai J Med 1995; 62(6): 439-44.
25. Mc Cormick GF, Zee C-S, Heiden J. Cysticercosis cerebri: review of 127 cases. Arch Neural 1982; 39: 534-9.
26. Shanley JD, Jordan CM. Clinical aspects of CNS cysticercosis. Arch Intern Med 1980; 140: 1309-13.
27. Scharf D. Neurocystkercosis: Two hundred thirty-eight cases from a California hospital. Arch Neural 1988; 45: 777-80.
28. Schantz PM, Moore AC, Munoz JL, Hartman BJ, Schaefer JA, et al. Neurocysticercosis in a Orthodox Jewish Community in New York City N Engl J Med 1992; 327 (10): 692-5. 
29. Yong JL, Warren BA Neurocysticercosis: a report of four cases. Pathology 1994; 25(3): 244-9.
30. Nash TE, Neva FA Recent advances in the diagnosis and treatment of cerebral cystkercosis. N Engl J Med 1984; 311: 1492-6.
31. Del Brutto OH, Castillo PR, Mena I, Freire A Neurocysticercosis among patients with cerebral gliornas. Arch Neural 1997; 54: 112S-8.
32. Canto C, Barinagarrementeria F. Cerebrovaccular complications of neurocysticercosis. Arch Neural 1996; 53: 233-9.
33. Barinagarrementeria F, Del Brutto OH, Otero E. Ataxic hemiparesis cystkercosis. Arch Neural 1988; 45: 246.
34. Bonametti AM, Baldy JL, Bortoliero AI, Maio C, Passos J, et al. Neurocisticercose cam quadro clínico inicial de meningite aguda. Rev Inst Med Trop Sao Paulo 1994; 36: 27-32. 
35. White AC, Dakick H, Diaz P. Asymptomatic neurocysticercosis in a patient with AIDS and cryptococcal meningitis. Am J Med 1995; 99: 101-2.
36. Moro PL, Guevara A, Veristegui M, Gilman RH, Poma H, et al. The Cysticercosis Working Group in Peru. Distribution of hydatidosis and cysticercosis in different Peruvian populations as demonstrated by enzyme-linked immunoelectrotransfer blot (EITB) assay Am J Trop Med Hyg 1994; 51: 851-5.
37. Diaz JF Verastegui M, Gilman RH, T sang V, Pitcher JB, et al. The Cysticercosis Working Group in Peru. Immunodiagnosis of cysticercosis: A field comparison of an antibody ELISA, an antigen-ELISA, and an EITB assay in Peru Am J Trop Med Hyg 1992;46:6 10-5. 38. Tellez-Girón E, Rams MC, Dufour L, Alvarez P, Montante M. Detection of Cysticercus cedulosae antigens in cerebrospinal fluid by dot enzyme-limned immunosorbent assay (Dot-ELISA)and standard ELISA. Am J Trop Med Hyg 1987;37(1): 169-73.
39. Tsang VC, Brand JA, Boyer AE. Am enzyme-linked immunoelectrotransfer blot assay and glycoprotein antigens for diagnosing human cysticercosis (Taenia solium). J Infect Dis 1989; 159(1): 50-9.
40. Moro PL, Gilman RH Wilson M, Schantz PM, Veristegui M, Garcia HH, Miranda E.
Immunoblot (Western blot) and double diffusion (DD5) test for hydatid diseases cross-react with sera from patients with cysticercosis. Trans R Sot Trop Med Hyg 1992;86:422-3.
41. VazAJ, Nunes CM, Pfazza R, LivramentoJ, Da Silva M,Nakamura Pferreira
W Immunoblot with cerebrospinal fluid from patients with neurocysticercosis using antigen from cysticerci of Taenia solium and Taenia wssiceps.Am J Trop Med Hyg 1997;57(3):354-7.
42.Kramer LID, Locke GE, Byrd S, Daryabagi J. Cerebral cysticercosis: Documentation of natural history with computed tomography. Radiology 1989;171:459-62.
43. Figueroa J. Tomografia Axial Computardada y Resonancia Magnética Nuclear en el diagnóstico de la Neurocisticercosis: Comparación de sensibilidades (Tesis de Bachiller) Lima, Perú: Universidad Peruana Cayetano Heredia, 1998.
44. Catacora M. Western Blot en Neurocisticercosis: Correlato inmuno-radiológico: Evolución luego dal tratamiento con albendazol (Tesis de Bachiller) Lima, Peru: Universidad Peruana Cayetano Heredia, 1996.
45. Escobedo F, Penagos P, Rodrfguez-Carbajal J, Sotelo J. Albendazole therapy for neurocystkercosis. Arch Intern Med 1987; 147:73-41.
46. Sotelo J, Torres B, Rubio-Donnadieu F, Escobedo F, Rodrfguez-Carbajal J. Praziquantel in the treatment of neurocysticercosis: Long- term follow-up. Neurology 1985; 35:752-5. 47. Kramer L. Medical treatment of cysticercosis-ineffective. Arch Neural 1995; 52: 101-2. 48. Del Brutto OH. Medical treatment of cysticercosis-effective. Arch Neural 1995; 
52: 102-4.
49. Hachinski V. Medical treatment of cysticercosis.Arch Neural 1995; 52: 104.
50. Rocca ED, Dávila A. Praziquantel y la cisticercosis. Diagnóstico 1986; 18(5): 147-50.
51. Sotelo J, Penagos P, Escobedo F, Del Brutto OH. Short course of albendazole therapy for neurocysticercosisArch Neural 1988; 45: 1130-3.
52. Sotelo J, Guerrero V, Rubio F Neurocysticercosis: a new classification based on active and inactive forms: a study of 753 cases. Arch Intern Med 1985; 145:442-5.
53. Dichter MA. Epilepsias y trastornos convulsivos. En: Harrison. Principios de Medicina Interna. Interamericana Mc Graw-Hill. Mexico. 1989. 2337-48.
54. Lechevalier B, Delaporte P, Creissard P. Patología infecciosa y parasitaria En: Manual de Neurologla. Cambier J. Masson M, Dehen H. Editorial Barcelona 1988;427-40.
55. Lechevalier B, Delaporte P, Creissard P Sindrome piramidal. En: Manual de Neurología. Cambier J, Masson M, Dehen H. Editorial Barcelona 1988; 43-46.
56. Wilson M, Bryan RT, Fried JA, Ware DA, Schantz PM, Pilcher JB. Clinical evaluation of the cysticercosis enzyme-linked immunoelectrotransfer blot in patients with neurocysticercosis.J Infect Dis 1991; 164:1007-9,
57. Wiederholt WC, Grisolia JS. Cysticercosis: An old scourge revisited
Arch Neural 1982; 39: 533.
58. Garcia HH, Gilman RH, Martinez M, TsangY et al. The Cysticercosis Working Group in Peru. Cysticercosis as a major cause of epilepsy in Peru. Lancet 1993; 341: 197-200.
59. Schantz PM, Sarti E, Plancarte A, Wilson M, et al. Community-based epidemiological investigations of cysticercosis due to Taenia solium Comparison of serological screening tests and clinical findings in two populations in Mexico Clin infect Dis 1994; 18:879-85. 
60. Silva-Vergara ML, Vieira C, Castro JH, Micheletti LG, Otaño A,
et al. Achadosneurológicos e laboratoriais em populacao de irea enddmica para teniase-cisticercose, Lagamar, MG, Brasil (1992-1993). Rev Inst Med Trop Sao Paulo 1994;36(4):335-42.
61. Garcia J, Allan JC, Fletes C, Moreno E, De Mata F, et al. Epidemiology of Taenia solium teniasis and cysticercosis in two rural Guatemalan communities. Am J Trop Med Hyg 1996; 55(3): 282-9.
62. Pozo M: Neurocisticercosis en niños: Experiencia en el Hospital Nacional Cayetano Heredia (Tesis de Bachiller) Lima, Perú: Universidad Peruana Cayetano Heredia, 1998. 63. Rangel R,Torres B, Del Brutto, Sotelo J. Cysticercotic encephalitis: A severe form in young females. Am J Trop Med Hyg 1987; 36(2):387-92.
64. Garcia HH, Gilman RH, Tovar MA, Flares E, Jo R, et al. The CysticercosisWorking Group in Peru. Factors associated with Taenia solium cysticercosis: analysis of nine hundred forty-six Peruvian neurologic patients. Am J Trop Med Hyg 1995; 52(2): 145-8.
65. Cuetter AC, Garcia-Bobadilla J, Garcia LG, Martínez FM, Kaim B. Neurocysticercosis: Focus on intraventricular disease. Clin Infect Dis 1997;24(2): 157-64.
66. Moore AC, Ludwic kLl, Schantz PM, Pilcher JB, et el. Seroprevalence
of cysticercosis in a Orthodox Jewish Community Am
J Trop Med Hyg 1995;53(5):439-42.
67. Agapejev S, Da Silva MD, Ueda AK. Severe forms of neurocysticercosis:
treatment with albendazole.
Arq Neuropsiquiatr 1996: 54(1):82-93.

68. Del Brutto OH. Single parenchymal brain cysticercus in the acute encephalitic fase: definition of a distinct form of neurocysticercosis with a benign prognosis. J Neural Neurosurg Psychiatry 1995; 58(2):247-9.
69. Latovitzki NAbrams G, Clark C,Mayeux RAscherl G,Sciarra D .Cerebral cysticercosis. Neurology 1978;28:838-42.
70. VlsquezV,SoteloJ.The course of secures after treatment for cerebral neurocysticercosis. N Engl J Med 1992; 327 (10): 696-701.
71. Bello E, De Gorgolas M,AIbisuaJ, Ruiz P, et al. Neurocysticercosis in a tertiary hospital. New advances in the diagnosis and treatment. Rev Clin Esp 1997, 197.604- 10.
72. Cruz ME, Cruz I, Preux PM, Schantz P, Dumas M. Headache and neurocysticercosis in Ecuador, southamerica Headache 1995; 35(2): 93-7.
73. Lamont EB, Sayah A. An occult cause of persistent nausea and vomiting. J Emerg Med 1997; 15(5):633-5.
74. Levy AS, Lillehei KO, Rubinstein D, Stears JC. Subarachnoid neurocysticercosis with occlusion of the major intracraneal arteries: case report. Neurosurgery 1995; 36: 183-8. 75. Rabiela MT, Rivas A, Castillo S, Gorziles A. Pruebas morfológicas de qua C. cellulosae y C. racemosus son larvas de Taenia solium.Arch Invest Med (Mex) 1985; 16:81-92.
76. Forlenza OV, Filho AH, Nobrega JP, Dos Ramos L, et al. Psychiatric manifestations of neurocysticercosis: a study of 38 patients from a neurology clinic in Brazil Neural Neurosurg Psychiatry 1997,62 (6):612-6.
77. Botero D, Tanowitz H, Weiss L, Wittner M. Taeniasis and cystcercosis. Infect Dis Clin NorthArn 1993;7:683-97.
78. Schmidt DK, Jordaan HF, Schneider JW, Cilliers J. Cerebral and subcutaneous cysticercosis treated with albendazole Int J Dermatol 1995;34(8):574-9.
79. Richards F Schantz PM. Cysticercosis and taeniasis. N Engl J Med 1985; 312:787-8.
80. Herrera G: Aspectos radiológicos de la neurocistkercosis. (tesis Doctoral) Lima, Perú: Universidad Peruana Cayetano Heredia, 1971.
81. Martinez HR, Rangel-Guerra R. Elizondo G. MR imaging in neurocysticercosis: a study of 56 cases. Am J Neuroradiol 1989; 10: 1011- 19.
82. Rawlings D, Ferreira D, Messing RO. Early computed tomography reevaluation after empiric praziquantel therapy in neurocysticercosis. Neurology 1989; 39:739-41.
83. Martinez HR, Rangel R. Arredondo JH, Marfil A,OnofreJ.Medicalandsurgicaltreatment in neurocysticercosis a magnetic resonance study of 151 cases.- Neural Sci 1995;130:25-34. 84. Garcia HH,Herrera G, Gilman RH,TsangV PilcherJB,et al.The CysticercosisWorkingGroup in Peru. Discrepancies between cerebral computed tomography and Western blot in the diagnosis of neuracysticercosis.AmJTrop Med Hyg 1994;50(2): 152-7.
85. Thornton CA, Houston S, LatifAS. Neurocysticercosis and Human Immunodeficiency Virus Infection: possible association.Arch Neural 1992;49:963-5.
86. Soto JL, Ostrosky L,Tavera J, G6mezA. Neurocysticercosis and HIV infection: report of two cases and review. Surg Neural 1996;45(1): 57-61.
87. Dumas JL,Visy JM, Belin C, Gast6n A, Goldlust D, Dumas M. Parenchymal neurocysticercosis follow-up and staging by MRI. Neuroradiology 1997; 39(1): 12-8. 88. Carpio A, Placencia M, Santillan F, Escobar A. A proposal for classification of neurocysticercosis. Can J Neural Sci 1994; 21(1):43-7.
89. CarpioA, Santillan F, Leon P, Flores C, HauserWA Is the course of neurocysticercosis modified by treatment with andhelminthic agents?.Arch Inter Med 1995; 155; 1982-8. 90. Sotelo J, Escobedo F, Penagos P Albendazole vs praziquantel for therapy for neurocysticercosis.Arch Neural 1988;45: 532-4.
91. Del Brutto OH,SoteloJ, Roman GC.Therapy for neurocysticercosis:A reappraisal. Clin Infect Dis 1993;17:730-5.
92. De Ghetaldi LID, Norman RM, DouvilleA. Cerebral cysticercosis treated biphasically with dexamethasone and praziquantelAnn Intern Med 1983;99:179-8I.
93. White AC, Shandera WX. Seizures and treatment for cerebral neurocysticercosis. Engl J Med 1992; 327 (27): 1955-6.
94. Robles C,Vargas N,SedanoAM.The chemotherapy of cysticercosis.The results 10 years or more after follow-up. Gac Med Mex 1997,133(2):127-39.
95. Proano JV, Madrazo I, Garcia L, Garcia E, Correa D.Albendazole and praziquantel treatment in neurocysticercosis of the fourth ventricle. j Neurosurg 1997,87(1):29-33.
%. Garcia HH, Gilman RH, et al.The Cysticercosis Group in Peru. Serologic evolution of neurocysticercosis patients after antiparasRic therapy.) Infect Dis 1997; 175(2):486-9. 
97. GarciaHH,GilmanRH,HortonJ,MartinezM,HerreraG,etal.TheCysticercosisWorking Group in Peru. Albendazole therapy for neurocysticercosis: a prospective doble blind trial comparing 7 versus 14 days of treatment. Neurology 1997;48(5): 1421-7.
98. Cruz I, Cruz ME, Carrasco F, Horton H. Neurocysticercosis: optimal dose treatment with albendazole.J Neural Scl 1995, 133 (I-2): 152-4.
99. Sotelo J, Del Brutto OH, Penagos P, et al. Comparison of therapeutic regimen of anticysticercal drugs for parenchymal brain cysticercosis.J Neural 1990; 237:69-72.
100 Sotelo J, Escobedo F, Rodrfguez-Carbajal J,Torres B, Rubio-Donnadieu FTherapy of parenchymal brain cysticercosis with praziquantel. N Engl J Med 1984;310: 1001-7. 
101. Bang OY HeojH,Choi SA,Kim DI. Large cerebral infarction during praziquantel therapy in neurocysticercosis.Stroke 1997;28(1):21 I-3.
102. VisquezjL,Jung H, Sotelo J. Plasma levels of praziquantel decrease when dexamethasone is given simultaneously Neurology 1987; 37: 1561-2.
103. Del Brutto OH. Prognosis factors for seizures recurrence after withdrawal of antiepileptic drugs in patients with neurocysticercosis. Neurology 1994;44(9):1706-9.

Regresar al Artículo